CD274 and neoplasm: Our first in vivo data revealed high and specific tumour uptake of 18F-AlF-NOTA-ZPD-L1 in mice bearing subcutaneous PD-L1-positive tumours (U87-MGvIII) and very low nonspecific uptake in PD-L1-negative tumours (H292PD-L1KO).